腹膜后平滑肌肉瘤侵犯肾静脉、下腔静脉1例报告

黄正楷, 易小敏, 邹君杰, 顾民, 王增军, 居小兵

黄正楷, 易小敏, 邹君杰, 顾民, 王增军, 居小兵. 腹膜后平滑肌肉瘤侵犯肾静脉、下腔静脉1例报告[J]. 实用临床医药杂志, 2021, 25(5): 83-86. DOI: 10.7619/jcmp.20201458
引用本文: 黄正楷, 易小敏, 邹君杰, 顾民, 王增军, 居小兵. 腹膜后平滑肌肉瘤侵犯肾静脉、下腔静脉1例报告[J]. 实用临床医药杂志, 2021, 25(5): 83-86. DOI: 10.7619/jcmp.20201458
HUANG Zhengkai, YI Xiaomin, ZOU Junjie, GU Min, WANG Zengjun, JU Xiaobing. Retroperitoneal leiomyosarcoma involving the renal vein and inferior vena cava: a case report[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 83-86. DOI: 10.7619/jcmp.20201458
Citation: HUANG Zhengkai, YI Xiaomin, ZOU Junjie, GU Min, WANG Zengjun, JU Xiaobing. Retroperitoneal leiomyosarcoma involving the renal vein and inferior vena cava: a case report[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 83-86. DOI: 10.7619/jcmp.20201458

腹膜后平滑肌肉瘤侵犯肾静脉、下腔静脉1例报告

详细信息
    通讯作者:

    居小兵, E-mail: doctorjxb@njmu.edu.cn

  • 中图分类号: R738.7;R572.2

Retroperitoneal leiomyosarcoma involving the renal vein and inferior vena cava: a case report

  • 摘要: 1例32岁女性患者因右侧间断性腰痛入院,影像学检查提示,腹膜后占位,压迫右肾、下腔静脉。患者行右肾根治性切除术联合下腔静脉人造血管移植术,术后病理检查显示为腹膜后平滑肌肉瘤,术后予以多柔比星、环磷酰胺、顺铂化疗。术后复查见下腔静脉血栓形成,予利伐沙班抗凝治疗。随访半年无不适、复发或转移。
    Abstract: A 32-year-old female patient was admitted to hospital due to intermittent right pain in waist. Imaging findings revealed a retroperitoneal space occupying which compressed right kidney and inferior vena cava. Radical nephrectomy combined with artificial vascular transplantation were performed. Pathological examination confirmed as retroperitoneal leiomyosarcoma. Chemotherapy of doxorubicin, cyclophosphamide and cisplatin in combination was used after surgery. Rivaroxaban was given for anticoagulation due to inferior vena cava thrombosis during the follow-up. No discomfort, recurrence or metastasis were found after half a year follow-up.
  • 图  1   腹膜后平滑肌肉瘤影像学资料

    A: MRI T2WI图; B: MRI DWI图; C: MRI冠状面重建; D: 增强CT图。

    图  2   腹膜后平滑肌肉瘤术后病理图

    A: HE染色(放大倍数40倍); B: 荧光显微镜下FISH检测

  • [1]

    RAJIAH P, SINHA R, CUEVAS C, et al. Imaging of uncommon retroperitoneal masses[J]. Radiographics: a review publication of the Radiological Society of North America, Inc, 2011, 31(4): 949-76. doi: 10.1148/rg.314095132

    [2]

    COOLEY C L, JAGANNATHAN J P, KURRA V, et al. Imaging features and metastatic pattern of non-IVC retroperitoneal leiomyosarcomas: are they different from IVC leiomyosarcomas[J]. Journal of computer assisted tomography, 2014, 38(5): 687-92. doi: 10.1097/RCT.0000000000000097

    [3] 陈贵兵, 晏阳, 肖春红, 等. 原发性腹膜后平滑肌肉瘤局部复发和预后分析[J]. 中华外科杂志, 2014, 52(2): 105-108. doi: 10.3760/cma.j.issn.0529-5815.2014.02.006
    [4] 王关卉儿, 何廉波, 杨恺惟, 等. 腹膜后平滑肌肉瘤11例临床及病理分析[J]. 中华泌尿外科杂志, 2016, 37(12): 916-919. doi: 10.3760/cma.j.issn.1000-6702.2016.12.010
    [5] 杨文昶, 李睿东, 张鹏, 等. 原发性腹膜后平滑肌肉瘤31例诊治分析[J]. 腹部外科, 2019, 32(6): 435-438. doi: 10.3969/j.issn.1003-5591.2019.06.011
    [6]

    OLIMPIADI Y, SONG S, HU J S, et al. Contemporary Management of Retroperitoneal Soft Tissue Sarcomas[J]. Current oncology reports, 2015, 17(8): 39. doi: 10.1007/s11912-015-0462-0

    [7]

    SHINDO S, MATSUMOTO H, OGATA K, et al. Surgical treatment of retroperitoneal leiomyosarcoma invading the inferior vena cava: report of three cases[J]. Surgery today, 2002, 32(10): 929-933. doi: 10.1007/s005950200185

    [8] 房杰, 沈晨阳, 李清乐, 等. 腹膜后平滑肌肉瘤侵犯下腔静脉1例[J]. 中外健康文摘, 2010, 7(31): 113-113. https://www.cnki.com.cn/Article/CJFDTOTAL-RMJZ201602060.htm
    [9]

    MARKO J, WOLFMAN D J. Retroperitoneal Leiomyosarcoma From the Radiologic Pathology Archives[J]. Radiographics: a review publication of the Radiological Society of North America, Inc, 2018, 38(5): 1403-1420. doi: 10.1148/rg.2018180006

    [10] 李晶英, 冯元春, 赵殿江. 腹膜后平滑肌肉瘤的临床、CT表现及病理分析[J]. 中国CT和MRI杂志, 2018, 16(2): 48-50. https://www.cnki.com.cn/Article/CJFDTOTAL-CTMR201802015.htm
    [11]

    STORM F K, MAHVI D M. Diagnosis and management of retroperitoneal soft-tissue sarcoma[J]. Annals of surgery, 1991, 214(1): 2-10. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1358407

    [12]

    LI B, LUO C H, ZHENG W. Risk factors for recurrence and survival in patients with primary retroperitoneal tumors[J]. Journal of BUON: official journal of the Balkan Union of Oncology, 2013, 18(3): 782-787. http://europepmc.org/abstract/med/24065499

    [13]

    HARTMAN D S, HAYES W S, CHOYKE P L, et al. From the archives of the AFIP. Leiomyosarcoma of the retroperitoneum and inferior vena cava: radiologic-pathologic correlation[J]. Radiographics: a review publication of the Radiological Society of North America, Inc., 1992, 12(6): 1203-1220. doi: 10.1148/radiographics.12.6.1439022

    [14]

    TEIXEIRA F J R, JR., DO COUTO NETTO S D, PERINA A L F, et al. Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection[J]. Oncology letters, 2017, 14(4): 3909-3916. doi: 10.3892/ol.2017.6706

    [15]

    LIU D, REN H L, LIU B, et al. Renal Function Preservation in Surgical Resection of Primary Inferior Vena Cava Leiomyosarcoma Involving the Renal Veins[J]. European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery, 2018, 55(2): 229-239. doi: 10.1016/j.ejvs.2017.11.031

    [16]

    PANTOJA J L, PATEL R P, BARIL D T, et al. Caval reconstruction with undersized ringed graft after resection of inferior vena cava leiomyosarcoma[J]. Ann Vasc Surg, 2020, 65: 25-32. doi: 10.1016/j.avsg.2019.11.007

    [17]

    KALLURI A G, JAIN A K, RODRIGUEZ H E, et al. Polytetrafluoroethylene is a safe and effective interposition conduit for caval reconstruction after resection of primary leiomyosarcoma of the inferior vena cava[J]. Ann Vasc Surg, 2019, 58: 289-294. doi: 10.1016/j.avsg.2018.12.068

    [18]

    PERVAIZ N, COLTERJOHN N, FARROKHYAR F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma[J]. Cancer, 2008, 113(3): 573-581. doi: 10.1002/cncr.23592

    [19]

    LE CESNE A, OUALI M, LEAHY M G, et al. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase Ⅲclinical trials[J]. Annals of oncology: official journal of the European Society for Medical Oncology, 2014, 25(12): 2425-2432. doi: 10.1093/annonc/mdu460

    [20] 李倩, 周宇红, 王妍, 等. 吉西他滨联合多西他赛一线治疗复发/转移性腹膜后平滑肌肉瘤[J]. 肿瘤, 2015, 35(1): 65-71. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLL201501011.htm
    [21]

    VAN DER GRAAF W T, BLAY J Y, CHAWLA S P, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial[J]. Lancet, 2012, 379(9829): 1879-1886. doi: 10.1016/S0140-6736(12)60651-5

  • 期刊类型引用(3)

    1. 张盼,王禺,李秀娥,王彩娥,刘媛. 纤维蛋白原、D-二聚体及血栓四项在中老年肾病综合征患者检测中的应用价值. 中国临床实用医学. 2024(05): 29-34 . 百度学术
    2. 顾志坚. 血清降钙素原在重症感染患者临床治疗中的应用效果探讨. 系统医学. 2021(14): 35-38 . 百度学术
    3. 乐大峰,杨君华,李声凤. 肾病综合征合并感染患者血清D-二聚体、IL-6、TNF-α水平变化及临床意义. 热带医学杂志. 2021(09): 1205-1208 . 百度学术

    其他类型引用(0)

图(2)
计量
  • 文章访问数:  397
  • HTML全文浏览量:  276
  • PDF下载量:  5
  • 被引次数: 3
出版历程
  • 收稿日期:  2021-01-17
  • 网络出版日期:  2021-03-22
  • 发布日期:  2021-03-14

目录

    /

    返回文章
    返回
    x 关闭 永久关闭

    根据国家关于期刊质量管理的相关要求,为加强学术诚信体系建设,防范学术不端风险,《实用临床医药杂志》要求文章重复率不超过20%。即日起,请作者在向《实用临床医药杂志》投稿前先通过维普、万方等权威数据库进行论文查重检测。作者通过投审稿系统投稿时,需要提交稿件及本文重复率不超过20%的查重检测报告。

    鉴于作者在外部渠道查重易造成论文与成果泄漏,《实用临床医药杂志》官网联系了维普论文检测系统(链接地址:https://vpcs.fanyu.com/personal/jcmp)、万方检测系统(链接地址:http://jcmp.wfcheck.cn/),便于作者进行预查重检测。维普论文检测系统、万方检测系统为第三方检测,具体事宜请作者与检测方接洽(维普联系电话:400-607-5550;万方联系QQ:800856851;电话:18677087062)。

    同时,《实用临床医药杂志》编辑部提醒广大作者尽早关注“实用临床医药杂志”官方微信公众号,并登陆官方网站及投审稿系统进行投稿。

     


    《实用临床医药杂志》官方微信二维码

     

     

    《实用临床医药杂志》官方网站三维码